The upregulation of tryptophan hydroxylase-2 expression is important for premature ejaculation treatment with the selective serotonin reuptake inhibitor
- PMID: 34874128
- DOI: 10.1111/andr.13135
The upregulation of tryptophan hydroxylase-2 expression is important for premature ejaculation treatment with the selective serotonin reuptake inhibitor
Abstract
Background: Although there was some evidence to suggest that the serotonergic system in the brain played an important role in premature ejaculation (PE), tryptophan hydroxylase-2 (TPH2) is considered to be the key enzyme for the synthesis of 5-hydroxytryptamine (5-HT) and few studies have reported that brain TPH2 is involved in the regulation of ejaculation.
Objectives: This study aimed to investigate whether changes in brain TPH2 levels were associated with PE and to explore the effects of acute administration of dapoxetine on TPH2 expression in the brain of rats with rapid ejaculation.
Materials and methods: Based on the ejaculation frequency, the male rats were split into three groups: "rapid," "normal," and "sluggish" ejaculators. The level of 5-HT in the brain was determined by an enzyme-linked immunosorbent assay. TPH2 expression was detected by western blot analysis and immunohistochemistry.
Results: The results showed that the concentration of 5-HT and the expression of TPH2 in rapid rats were the lowest, while those in sluggish rats were the highest. Correlation analysis also indicated the level of TPH2 was positively correlated with ejaculation latency (r = 0.8633, p < 0.0001) and negatively correlated with ejaculation frequency (r = -0.874, p < 0.001). In addition, dapoxetine acute administration to rapid rats resulted in upregulation of TPH2 expression in the brain.
Discussion: There was an important link between the level of TPH2 and the change of ejaculation behaviors. Decreased expression of TPH2 in relevant brain regions will lead to rapid ejaculation. Moreover, the effect of dapoxetine on prolonging ejaculation may be due to the upregulation of TPH2 expression.
Conclusion: We found the correlation between the level of TPH2 in the brain and PE. The findings in this study will open up a novel way for future research in PE therapy.
Keywords: animal model; premature ejaculation; regulation of ejaculation; sexual behavior; tryptophan hydroxylases-2.
© 2021 American Society of Andrology and European Academy of Andrology.
Similar articles
-
The role of tyrosine hydroxylase within dapoxetine-assisted therapy against premature ejaculation.Mol Biol Rep. 2023 Apr;50(4):3515-3523. doi: 10.1007/s11033-022-08140-3. Epub 2023 Feb 14. Mol Biol Rep. 2023. PMID: 36787051
-
Endogenous Deficiency of Brain-Derived Neurotrophic Factor Induces the Downregulation of Tryptophan Hydroxylase-2 Expression in Raphe Nuclei of Rapid Ejaculator Rats.J Sex Med. 2021 Sep;18(9):1491-1499. doi: 10.1016/j.jsxm.2021.07.009. Epub 2021 Aug 9. J Sex Med. 2021. PMID: 34384732
-
Effect of dapoxetine on ejaculatory performance and related brain neuronal activity in rapid ejaculator rats.J Sex Med. 2012 Oct;9(10):2562-73. doi: 10.1111/j.1743-6109.2012.02884.x. Epub 2012 Aug 20. J Sex Med. 2012. PMID: 22906232
-
Pharmacotherapy for premature ejaculation.Expert Opin Pharmacother. 2015;16(17):2615-24. doi: 10.1517/14656566.2015.1096928. Epub 2015 Nov 18. Expert Opin Pharmacother. 2015. PMID: 26579971 Review.
-
Pharmacology for the treatment of premature ejaculation.Pharmacol Rev. 2012 Jul;64(3):621-44. doi: 10.1124/pr.111.004952. Epub 2012 Jun 7. Pharmacol Rev. 2012. PMID: 22679220 Review.
Cited by
-
Influence of TPH2 and HTR1A polymorphisms on lifelong premature ejaculation risk among the chinese Han population.BMC Urol. 2023 May 9;23(1):86. doi: 10.1186/s12894-023-01222-9. BMC Urol. 2023. PMID: 37161455 Free PMC article.
-
Sexual Motivation (Desire): Problems with Current Preclinical and Clinical Evaluations of Treatment Effects and a Solution.Behav Sci (Basel). 2025 May 9;15(5):642. doi: 10.3390/bs15050642. Behav Sci (Basel). 2025. PMID: 40426419 Free PMC article. Review.
-
The value of 5-HT, leptin, and NE in the classification of premature ejaculation.Sex Med. 2025 Jan 13;12(6):qfae086. doi: 10.1093/sexmed/qfae086. eCollection 2024 Dec. Sex Med. 2025. PMID: 39807473 Free PMC article.
-
Peripheral pathway gene variants in lifelong premature ejaculation: CYP19A1, CYP1A1, and CYP1A2 enzymes polymorphisms in Chinese Han men.Sex Med. 2024 Sep 19;12(4):qfae056. doi: 10.1093/sexmed/qfae056. eCollection 2024 Aug. Sex Med. 2024. PMID: 39301522 Free PMC article.
-
The role of tyrosine hydroxylase within dapoxetine-assisted therapy against premature ejaculation.Mol Biol Rep. 2023 Apr;50(4):3515-3523. doi: 10.1007/s11033-022-08140-3. Epub 2023 Feb 14. Mol Biol Rep. 2023. PMID: 36787051
References
REFERENCES
-
- Sansone A, Aversa A, Corona G, et al. Management of premature ejaculation: a clinical guideline from the Italian Society of Andrology and Sexual Medicine (SIAMS). J Endocrinol Invest. 2021;44(5):1103-1118.
-
- Salonia A, Bettocchi C, Boeri L, et al. European Association of Urology Guidelines on Sexual and Reproductive Health-2021 update: male sexual dysfunction. Eur Urol. 2021;80(3):333-357.
-
- Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007;51(3):816-824.
-
- Gao J, Zhang X, Su P, et al. Prevalence and factors associated with the complaint of premature ejaculation and the four premature ejaculation syndromes: a large observational study in China. J Sex Med. 2013;10(7):1874-1881.
-
- Waldinger MD. Ejaculatio praecox, erectio praecox, and detumescentia praecox as symptoms of a hypertonic state in lifelong premature ejaculation: a new hypothesis. Pharmacol Biochem Behav. 2014;121:189-194.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources